Insights

Publication | BRG white paper

340B Growth and the Impact on the Oncology Marketplace: Update

December 15, 2015

Aaron Vandervelde discusses the 340B Drug Discount Program, Medicare Part B hospital outpatient drug spend, and oncology drugs and practices.

Read the paper.

Professionals

Related Professionals

Aaron Vandervelde

Managing Director

Washington, DC